Deok-Hwan Yang

Haa-Na Song, Sung-Soo Yoon, S. Kim, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study

S. Oh, H. J. Kim, Deok-Hwan Yang, 2017, Oncotarget.

Treatment results of radiotherapy following CHOP or R-CHOP in limited-stage head-and-neck diffuse large B-cell lymphoma: a single institutional experience

Deok-Hwan Yang, M. Yoon, T. Nam, 2017, Radiation oncology journal.

Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patients.

H. Kang, J. Jo, Y. Do, 2016, Experimental hematology.

Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma.

Y. Lee, Y. Do, H. Yhim, 2016, Leukemia research.

Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study

Sung-Soo Yoon, Jin Seok Kim, H. Eom, 2016, Annals of Hematology.

Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.

J. Cheong, S. Kim, Jin Seok Kim, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weekly rituximab consolidation following four cycles of R‐CHOP induction chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: Consortium for improving survival of lymphoma study (CISL)

H. Kang, C. Suh, Y. Do, 2015, European journal of haematology.

Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma

Seong-Jang Kim, Junshik Hong, Moon Won Lee, 2015, Blood research.

High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.

J. H. Lee, J. Cheong, Y. Min, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement

Jae Hyun Kim, H. Song, Y. Do, 2013, Cancer research and treatment : official journal of Korean Cancer Association.

Absolute lymphocyte count at day + 21 predicts survival in patients with early-stage diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, adriamycin, vincristine and prednisone

Je-Jung Lee, Y. Chae, S. Sohn, 2012, Leukemia & lymphoma.

Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2011, The Korean journal of hematology.

Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation

Ji‐Won Kim, B. Kim, Inho Kim, 2011, Annals of Hematology.

The Impact of Hyperglycemia on Risk of Severe Infections during Early Period of Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, BioMed research international.

Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2018, BMC Cancer.

Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma.

H. Lee, Je-Jung Lee, I. Chung, 2011, Leukemia research.

Clinical outcomes of early-progressed follicular lymphoma in Korea: a multicenter, retrospective analysis

Jinny Park, S. Kim, C. Suh, 2022, Archives of Medical Science.

Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivity.

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2010, Cancer research and treatment : official journal of Korean Cancer Association.

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Jinny Park, J. H. Lee, Young-Uk Cho, 2013 .

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

Sukjoong Oh, Je-Jung Lee, Y. Cho, 2007, Cancer Chemotherapy and Pharmacology.

CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2006, Cancer Chemotherapy and Pharmacology.

Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen

Sukjoong Oh, Jin Seok Kim, Je-Jung Lee, 2015, Annals of Hematology.

Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts

K. Yoo, Byeong-Bae Park, S. Kim, 2022, Cancer research and treatment.

Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study

K. Yoo, Byeong-Bae Park, S. Kim, 2021, Cancer research and treatment.

Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas

Sae-Ryung Kang, H. Yhim, Je-Jung Lee, 2019, Annals of Hematology.

A Multi-Center International Survey Related to the Nutritional Support after Hematopoietic Stem Cell Transplantation Endorsed by the ASIA Pacific Blood and Marrow Transplantation (APBMT) *

N. Linton, Y. Kodera, R. Suzuki, 2012 .

Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea

Jae Hyun Kim, Jinny Park, J. Cheong, 2013, Journal of Korean medical science.

Activation by IL-2 T Cell + Unique Features of Naive CD8

J. Sprent, C. Surh, Deok-Hwan Yang, 2013 .

Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive

Sung-Soo Yoon, S. Kim, Jin Seok Kim, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen

Je-Jung Lee, Miyoung Kim, Hyeoung-Joon Kim, 2012, International Journal of Hematology.

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma

Kihyun Kim, S. Kim, S. Yoon, 2020, BMC Cancer.

Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2015, The Korean journal of internal medicine.

Clinical Correlation of CD4+CD25+ Regulatory T Cells in Early Immune Reconstitution after Myeloablative Allogeneic Stem Cell Transplantation

J. Park, Je-Jung Lee, Hyeoung-Joon Kim, 2009 .

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in Elderly Patients: a Pilot Trial

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2016 .

Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens

S. Chung, Je-Jung Lee, I. Chung, 2009, Annals of Hematology.

Optimization and limitation of calcium ionophore to generate DCs from acute myeloid leukemic cells.

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2007, Cancer research and treatment : official journal of Korean Cancer Association.

Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)

Junshik Hong, J. H. Lee, S. Kim, 2016, Oncotarget.

Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma

Jinny Park, S. Kim, Jin Seok Kim, 2011, Annals of Hematology.

Stage IV marginal zone B‐cell lymphoma – prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

Jinny Park, Dae-Ho Lee, I. Hwang, 2010, Cancer science.

FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma.

Yeon-Hee Park, Y. Do, M. K. Kim, 2006, Blood.

FCGR 3 A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma

Yeon-Hee Park, M. K. Kim, Je-Jung Lee, 2006 .

Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with Lymphoma

I. Oh, Je-Jung Lee, Miyoung Kim, 2013, Tuberculosis and respiratory diseases.

Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Journal of clinical apheresis.

In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer

H. Lee, B. Park, Je-Jung Lee, 2011, Experimental & Molecular Medicine.

Toxic Epidermal Necrolysis after Rituximab Therapy for Immune Thrombocytopenic Purpura

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2009 .

Pilot Remission Induction Therapy with Idarubicin, plus an Intensified Dose of Ara-C and Priming with Granulocyte Colony-Stimulating Factor for Acute Myeloid Leukemia

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2006, Acta Haematologica.

Hydroxymethylcytosine correlates with epigenetic regulatory mutations , but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2017 .

Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

M. Minden, S. Ogawa, Namshin Kim, 2015, Haematologica.

Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results

J. H. Lee, M. Kurosawa, J. Kuroda, 2022, Haematologica.

Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients

H. Kim, Je-Jung Lee, Hyeoung-Joon Kim, 2011, The Korean journal of hematology.

Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer.

J. Hwang, I. Chung, W. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant

M. Minden, C. Jung, Je-Jung Lee, 2015, Annals of Hematology.

The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2004, Journal of clinical apheresis.

Pineal Diffuse Large B-Cell Lymphoma Concomitant With Pituitary Prolactinoma: Possible Correlation Between 2 Distinguished Pathologies

Shin Jung, Kyung-Sub Moon, Kyung-Hwa Lee, 2016, Medicine.

Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial

H. Yhim, Je-Jung Lee, Hyeoung-Joon Kim, 2013, Annals of Hematology.

CD8+ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens

I. Oh, Sang‐Yun Song, Deok-Hwan Yang, 2021, Journal for ImmunoTherapy of Cancer.

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma

Je-Jung Lee, Miyoung Kim, Hyeoung-Joon Kim, 2012, Case Reports in Oncology.

Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2008, Leukemia research.

Efficacy and Safety of Micafungin as an Empirical Antifungal Agent for Febrile Neutropenic Patients with Hematological Diseases

Jin-Hyuk Choi, Kihyun Kim, C. Jung, 2010, Acta Haematologica.

Next‐generation sequencing‐based analysis to assess the pattern of relapse in patients with Philadelphia‐positive acute lymphoblastic leukemia

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2022, EJHaem.

A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma

F. Emmrich, J. Rhee, Je-Jung Lee, 2017, Oncotarget.

Adult T-cell leukemia/lymphoma with a complex karyotype and central nervous system involvement.

S. Suh, J. Sawyer, Hyeoung-Joon Kim, 2007, Cancer genetics and cytogenetics.

FLT3 Internal Tandem Duplication in Acute Myeloid Leukemia with Normal Karyotype

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2007 .

Prognostic significance of nucleophosmin mutations and FLT3 internal tandem duplication in adult patients with cytogenetically normal acute myeloid leukemia

H. Kim, Je-Jung Lee, Hyeoung-Joon Kim, 2010, The Korean journal of hematology.

Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.

J. Min, Y. Jeong, Je-Jung Lee, 2011, European journal of cancer.

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia

Zhaolei Zhang, C. Jung, Je-Jung Lee, 2022, Bone Marrow Transplantation.

Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

Y. Lee, Je-Jung Lee, Hyeoung-Joon Kim, 2018, Clinical lymphoma, myeloma & leukemia.

Tumor necrosis and complete resection has significant impacts on survival in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma

Seong-Jang Kim, H. Yhim, Je-Jung Lee, 2017, Oncotarget.

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2012, Case Reports in Oncology.

Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, BioMed research international.

A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2012, Annals of Hematology.

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2022, Cancer Immunology, Immunotherapy.

Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, International Journal of Hematology.

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2019, BMC Cancer.

Clinical Efficacy of Mitoxantrone and Ara-C with or without Etoposide Salvage Chemotherapy in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: Retrospective Multicenter Study of the Korean Adult ALL Working Party

Je-Jung Lee, S. Sohn, D. Jo, 2014, Acta Haematologica.

The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Y. Cho, Hyeoung-Joon Kim, Y. Chae, 2009 .

Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma

Je-Jung Lee, Hyeoung-Joon Kim, Sang‐Yun Song, 2021, Journal of Korean medical science.

Diagnostic accuracy and prognostic relevance of immunoglobulin heavy chain rearrangement and 18 F-FDG- PET/CT compared with unilateral bone marrow trephination for detecting bone marrow involvement in patients with diffuse large B-cell lymphoma

Hyeoung-Joon Kim, Je Jung Lee, Deok-Hwan Yang, 2021 .

Clinical characteristics and prognostic factors of acquired haemophilia A in Korea

Sung-Soo Yoon, Jin Seok Kim, Y. Do, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Efficacy and Safety of Micafungin as An Empirical Antifungal Agent for Febrile Neutropenic Patients with Hematological Diseases.

Jin-Hyuk Choi, C. Jung, S. Kim, 2009 .

Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea

Jinny Park, J. Cheong, Y. Min, 2013, Yonsei medical journal.

Polymyositis and myocarditis after donor lymphocyte infusion

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2009, International journal of hematology.

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.

Jong-Ho Won, Sang Kyun Sohn, Sung-Hoon Jung, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2015, Chonnam medical journal.

Cellular immunotherapy using dendritic cells against multiple myeloma

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2012, The Korean journal of hematology.

Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy

H. Lee, Je-Jung Lee, I. Chung, 2011, Cellular and Molecular Immunology.

Polymorphisms in DNA Repair Genes and MDR1 and the Risk for Non-Hodgkin Lymphoma

M. Shin, Jin-Su Choi, H. Kim, 2014, International journal of molecular sciences.

Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates

J. Rhee, Je-Jung Lee, I. Chung, 2007, Leukemia & lymphoma.

Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2021, Cellular & Molecular Immunology.

Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study

Sang‐wook Lee, S. Kim, H. Eom, 2014, Annals of Hematology.

Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2015, Blood research.

Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study

Jinny Park, S. Kim, H. Kang, 2012, Annals of Hematology.

STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, M. Shin, 2017, Blood research.

Clinical significance of clonality and Epstein‐Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis

Je-Jung Lee, Hyeoung-Joon Kim, S. Kim, 2010, American journal of hematology.

Treatment Outcomes with CHOP Chemotherapy in Adult Patients with Hemophagocytic Lymphohistiocytosis

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2008, Journal of Korean medical science.

Steroid-refractory Autoimmune Hemolytic Anemia Following Unrelated Allogeneic Peripheral Blood Stem Cell Transplantation

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2008 .

The Feasibility and Clinical Efficacy of In Vivo Adsorption of Isohemagglutinins with Fresh Frozen Plasma (FFP) Infusion in Major ABOincompatible Allogeneic Stem Cell Transplantation

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2005 .

Plerixafor use for peripheral blood stem cell mobilization in Korea

J. H. Lee, Sung-Soo Yoon, S. Kim, 2013, Blood research.

Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV‐seropositive recipients and donors

Je-Jung Lee, Y. Cho, Hyeoung-Joon Kim, 2008, American journal of hematology.

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study

Y. Min, C. Jung, Sung-Soo Yoon, 2010, Haematologica.

Development of a UPLC-MS/MS method for the therapeutic monitoring of L-asparaginase

Deok-Hwan Yang, K. Shin, Therasa Kim, 2018, Translational and clinical pharmacology.

Renal Adverse Effect of Anagrelide in Patients with Myeloproliferative Neoplasms

Je-Jung Lee, Hyeoung-Joon Kim, N. Kim, 2011 .

Polymorphisms of drug‐metabolizing genes and risk of non‐Hodgkin lymphoma

M. Shin, Jin-Su Choi, H. Kim, 2009, American journal of hematology.

Low-dose acyclovir is effective for prevention of herpes zoster in myeloma patients treated with bortezomib: a report from the Korean Multiple Myeloma Working Party (KMMWP) Retrospective Study.

Kihyun Kim, S. Kim, Y. Do, 2011, Japanese journal of clinical oncology.

Unique Features of Naive CD8+ T Cell Activation by IL-2

J. Sprent, C. Surh, Deok-Hwan Yang, 2013, The Journal of Immunology.

Association with TP53 codon 72 polymorphism and the risk of non‐Hodgkin lymphoma

M. Shin, Jin-Su Choi, H. Kim, 2010, American journal of hematology.

Ileovesical Fistula Caused by Hepatocellular Carcinoma

S. Choi, I. Chung, Deok-Hwan Yang, 2005, The Korean journal of internal medicine.

Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia

J. Lee, Yunsuk Choi, Y. Do, 2020, Yonsei medical journal.

Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment

Je-Jung Lee, Hyeoung-Joon Kim, Sang‐Yun Song, 2016, Scientific Reports.

Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.

Marc S. Tyndel, Zhaolei Zhang, Y. Lee, 2018, Blood.

Induction treatment with cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma: a phase II study.

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2010, Clinical lymphoma, myeloma & leukemia.

A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial

Junshik Hong, Jinny Park, S. Kim, 2016, Leukemia & lymphoma.

Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study

Jinny Park, Dae-Ho Lee, I. Hwang, 2010, International journal of hematology.

Pulmonary marginal zone B-cell lymphoma of MALT type—What is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) Study

Jinny Park, Dae-Ho Lee, I. Hwang, 2010, Annals of Hematology.

Relapsed or refractory nongastric marginal zone B‐cell lymphoma: Multicenter retrospective analysis of 92 cases

Jinny Park, Dae-Ho Lee, I. Hwang, 2009, American journal of hematology.

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma

Junshik Hong, J. H. Lee, S. Kim, 2017, Oncotarget.

A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.

J. Jo, J. Choe, D. Yoon, 2023, Expert opinion on biological therapy.

Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma

Deok-Hwan Yang, Ga-Young Song, Seo-Yeon Ahn, 2016, Blood research.

Serum Lactate Dehydrogenase with a Systemic Inflammation Score Is Useful for Predicting Response and Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Acta Haematologica.

High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy

Je-Jung Lee, D. Shin, Deok-Hwan Yang, 2015, International Journal of Hematology.

The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin’s lymphoma

J. Min, Y. Jeong, Je-Jung Lee, 2009, Annals of Hematology.

Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma

S. Kim, Jin Seok Kim, C. Suh, 2012, Leukemia & lymphoma.

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study

J. H. Lee, S. Kim, Jin Seok Kim, 2019, Cancer communications.

Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies.

M. Shin, Jin-Su Choi, H. Kim, 2009, Leukemia research.

DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome

H. Kim, Je-Jung Lee, Hyeoung-Joon Kim, 2011, Journal of Korean medical science.

Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma

Jin-Su Choi, H. Kim, Je-Jung Lee, 2007, American journal of hematology.

Association between folate‐metabolizing pathway polymorphism and non‐Hodgkin lymphoma

M. Shin, Jin-Su Choi, H. Kim, 2008, British journal of haematology.

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group

K. Izutsu, Y. Kwong, S. Kim, 2020, Journal of Hematology & Oncology.

Long‐term follow‐up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome‐positive acute lymphoblastic leukemia

S. Yun, C. Jung, M. K. Kim, 2015, American journal of hematology.

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.

Jinny Park, Young-Uk Cho, Kihyun Kim, 2015, Blood.

Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists

H. Lee, B. Park, Je-Jung Lee, 2011, Cellular and Molecular Immunology.

Clinical outcome of elderly patients with Epstein–Barr virus positive diffuse large B‐cell lymphoma treated with a combination of rituximab and CHOP chemotherapy

H. Yhim, Je-Jung Lee, Hyeoung-Joon Kim, 2013, American journal of hematology.

Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2010, Annals of Hematology.

Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation

Je-Jung Lee, I. Chung, Y. Mun, 2007, American journal of hematology.

Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma

J. Min, Je-Jung Lee, H. Bom, 2015, Chonnam medical journal.

Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders.

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2008, Leukemia research.

Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia

Junshik Hong, C. Jung, Sung-Soo Yoon, 2020, Journal of clinical medicine.

Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation

Junshik Hong, S. Kim, Jin Seok Kim, 2015, Annals of Hematology.

Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea

Dae-Ho Lee, Y. Ko, Kihyun Kim, 2009, Leukemia & lymphoma.

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study

S. Kim, H. Kang, H. Eom, 2016, Oncotarget.

Frontline therapy for newly diagnosed patients with multiple myeloma

J. Jo, Je-Jung Lee, Hyeoung-Joon Kim, 2019, Blood research.

Adrenal insufficiency in hospitalized patients with multiple myeloma

Ho-Cheol Kang, H. Kim, Je-Jung Lee, 2020, Leukemia & lymphoma.

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2019, BMC Cancer.

Clinical Efficacy of Thalidomide Containing Regimens as a Primary Therapy in Patients with Multiple Myeloma

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2006 .

The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma.

J. Rhee, S. Chung, J. Park, 2009, Leukemia research.

Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins

H. Lee, Je-Jung Lee, I. Chung, 2011, Annals of Hematology.

Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells

Je-Jung Lee, I. Chung, P. Kalinski, 2010, Annals of Hematology.

Induction of Myeloma Cell Line-specific Cytotoxic T Lymphocytes using Monocyte-derived Dendritic Cells Pulsed with Myeloma Cell Line Lysates

J. Park, Je-Jung Lee, I. Chung, 2006 .

Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2020, Bone Marrow Transplantation.

In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium

M. Jeong, Y. Ahn, J. Min, 2006, Annals of nuclear medicine.

The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase

J. Cheong, Y. Min, H. Kang, 2016, Annals of Hematology.

High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.

Seunghyeon Shin, Kyoungjune Pak, Deok-Hwan Yang, 2016, Leukemia research.

Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma

S. Oh, Deok-Hwan Yang, Ho-Jin Shin, 2019, Blood research.

Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09)

J. Huh, C. Suh, S. Oh, 2017, Oncotarget.

Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09)

J. Huh, C. Suh, S. Oh, 2020, Annals of Hematology.

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis

Y. Ko, S. Kim, C. Suh, 2020, Annals of Hematology.

Decreased body mass index is associated with poor prognosis in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Annals of Hematology.

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

J. Cheong, Kihyun Kim, Jin Seok Kim, 2016, BMC Cancer.

First-Line Dasatinib Plus Conventional Chemotherapy in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Interim Analysis of the Korean Prospective Phase II Study

Jin Seok Kim, H. Yhim, Yoo-Jin Kim, 2011 .

Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study

C. Jung, Sung-Soo Yoon, Je-Jung Lee, 2011 .

Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.

Zhaolei Zhang, S. Ogawa, Kenichi Yoshida, 2019, Experimental hematology.

18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System

J. Min, Je-Jung Lee, H. Bom, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score

J. Choi, Sungeun Kim, J. Lee, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma

J. Min, Y. Do, S. Kweon, 2015, BMC Cancer.

Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era

S. Kim, Jin Seok Kim, Y. Do, 2020, Scientific Reports.

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

M. Minden, C. Jung, Je-Jung Lee, 2016, Oncotarget.

Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma

J. Min, Je-Jung Lee, H. Bom, 2018, Clinical nuclear medicine.

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2016, Journal of Korean medical science.

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2016, Annals of Hematology.

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2023, The Korean journal of internal medicine.

Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist

J. Rhee, J. Min, B. Park, 2010, Experimental & Molecular Medicine.

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

J. Cheong, Kihyun Kim, Jin Seok Kim, 2016, BMC Cancer.

The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer.

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2007, Cancer research and treatment : official journal of Korean Cancer Association.

RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia

Marc S. Tyndel, Zhaolei Zhang, J. Cheong, 2020, Scientific Reports.

Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2013, International Journal of Hematology.

Multiple brain biopsies for EBV-positive diffuse large B-cell lymphoma with extensive necrosis in a post-transplant patient: A case report.

Sae-Ryung Kang, T. Jung, Kyung-Hwa Lee, 2019, World neurosurgery.

Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2018, BMC Cancer.

The clonal origins of leukemic progression of myelodysplasia

S. Y. Kim, Marc S. Tyndel, Zhaolei Zhang, 2016, Leukemia.

A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment

J. Min, Y. Jeong, Je-Jung Lee, 2011, Case Reports in Oncology.

Clinical characteristics analysis of sinonasal diffuse large b-cell lymphoma and extranodal nk/t-cell lymphoma.

Deok-Hwan Yang, D. Lee, S. Lim, 2023, International forum of allergy & rhinology.

The clinical outcomes of autologous stem cell transplantation in peripheral T cell lymphoma: From retrospective Multicenter study in Korea.

S. Kim, Jin Seok Kim, W. Kim, 2007 .

All-trans Retinoic Acid-induced Nephrotic-range Proteinuria in a Patient with Acute Promyelocytic Leukemia

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2008 .

Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype

Zhaolei Zhang, C. Jung, Y. Lee, 2017, Oncotarget.

Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression

H. Choi, E. Hwang, Je-Jung Lee, 2016, Annals of Hematology.

Survival Prediction Using Transformer-Based Categorical Feature Representation in the Treatment of Diffuse Large B-Cell Lymphoma

Hyung-Jeong Yang, Sae-Ryung Kang, Deok-Hwan Yang, 2023, Healthcare.

The Clinical Efficacy of R-CHOP Chemotherapy in Patients with Previously Untreated Diffuse Large B-cell Lymphoma

H. Song, Y. Do, Je-Jung Lee, 2004 .

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2023, Cancer research and treatment : official journal of Korean Cancer Association.

A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

K. Yoo, H. Kang, H. Eom, 2023 .

Prognostic Significances of ABCG-2 and hOCT-1 Gene Expression in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate.

H. Kim, Je-Jung Lee, Hyeoung-Joon Kim, 2009 .

Je-Jung Lee, I. Chung, Hyeoung-Joon Kim, 2008, Leukemia research.

Recent Updates on Diagnosis and Treatment of Follicular Lymphoma

Deok-Hwan Yang, G. Song, 2023, The Korean Journal of Medicine.

Cellular immunotherapy using dendritic cells against multiple myeloma

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2012, The Korean journal of hematology.

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

C. Choi, H. Eom, H. Yhim, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation

K. Yoo, S. Kim, H. Eom, 2023, Blood cancer journal.

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

S. Kim, H. Kang, H. Eom, 2023, Frontiers in oncology.

A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study

H. Eom, J. Jo, Deok-Hwan Yang, 2023, Blood research.

Stage IV marginal zone B‐cell lymphoma – prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

Jinny Park, Dae-Ho Lee, I. Hwang, 2010, Cancer science.